Last reviewed · How we verify
strontium chloride hexahydrate
strontium chloride hexahydrate is a Small molecule drug developed by Smerud Medical Research International AS. It is currently in Phase 3 development. Also known as: 2PX.
At a glance
| Generic name | strontium chloride hexahydrate |
|---|---|
| Also known as | 2PX |
| Sponsor | Smerud Medical Research International AS |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus (PHASE2)
- Successful Pregnancy and Delivery After AOA (NA)
- Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer (PHASE3)
- Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases (PHASE4)
- The Strontium Chloride Associated With Photobiomodulation in the Control of Post-bleaching Sensitivity (NA)
- Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases (PHASE2)
- Novel Approach With Double Agent Artificial Oocyte Activation for Repeated Fertilization Failure Due to Combined Sperm and Oocyte Factor (NA)
- Artificial Oocyte Activation Comparing Tow Different Agents (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- strontium chloride hexahydrate CI brief — competitive landscape report
- strontium chloride hexahydrate updates RSS · CI watch RSS
- Smerud Medical Research International AS portfolio CI
Frequently asked questions about strontium chloride hexahydrate
What is strontium chloride hexahydrate?
strontium chloride hexahydrate is a Small molecule drug developed by Smerud Medical Research International AS.
Who makes strontium chloride hexahydrate?
strontium chloride hexahydrate is developed by Smerud Medical Research International AS (see full Smerud Medical Research International AS pipeline at /company/smerud-medical-research-international-as).
Is strontium chloride hexahydrate also known as anything else?
strontium chloride hexahydrate is also known as 2PX.
What development phase is strontium chloride hexahydrate in?
strontium chloride hexahydrate is in Phase 3.
Related
- Manufacturer: Smerud Medical Research International AS — full pipeline
- Also known as: 2PX
- Compare: strontium chloride hexahydrate vs similar drugs
- Pricing: strontium chloride hexahydrate cost, discount & access